Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. S-1/A Offering Registration Statement
  2. UPLOAD Other SEC-generated Letter
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. 8-A12B Other Registration of Securities
  6. S-1/A Offering Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-1 Offering Registration Statement
  12. UPLOAD Other SEC-generated Letter
  13. DRS/A Other Draft Registration Statement
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. DRS/A Other Draft Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. DRS/A Other Draft Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 11 of 12 · 224 filings